Discover how labs across the world use our core technology to achieve faster decisions and greater productivity in precision medicine.
The VeriDose Core Panel targets the most relevant variants in 20 principle genes implicated in drug metabolism pathways. It provides genotype information for 68 SNPs/INDELs across 20 genes. The panel is designed to be tolerant to low quality DNA, boosting the likelihood of success with challenging samples.
Learn MoreMarch 27 webinar on accelerated results and higher success rates characterizing genetic profile of lung adenocarcinomas, by supplementing NGS with the MassARRAY platform, including…
Register NowDate: March 19, 2024
Location: Online
Date: March 27, 2024
Location: Online
29 November 2021
14 September 2021